FR3099060B1 - Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique - Google Patents

Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique Download PDF

Info

Publication number
FR3099060B1
FR3099060B1 FR1908575A FR1908575A FR3099060B1 FR 3099060 B1 FR3099060 B1 FR 3099060B1 FR 1908575 A FR1908575 A FR 1908575A FR 1908575 A FR1908575 A FR 1908575A FR 3099060 B1 FR3099060 B1 FR 3099060B1
Authority
FR
France
Prior art keywords
mineral
cosmetic
skin
maintaining
organic hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1908575A
Other languages
English (en)
Other versions
FR3099060A1 (fr
Inventor
Han Athalin
JEAN-NOëL THOREL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionuclei
Original Assignee
Bionuclei
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionuclei filed Critical Bionuclei
Priority to FR1908575A priority Critical patent/FR3099060B1/fr
Priority to PCT/EP2020/070642 priority patent/WO2021018682A1/fr
Priority to CN202080053365.4A priority patent/CN114667130A/zh
Priority to EP20740649.7A priority patent/EP4003269A1/fr
Publication of FR3099060A1 publication Critical patent/FR3099060A1/fr
Application granted granted Critical
Publication of FR3099060B1 publication Critical patent/FR3099060B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/612By organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/614By macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Complexe hybride minéral et organique comprenant des colloïdes de silice greffés de manière covalente avec au moins un peptide ou son précurseur.
FR1908575A 2019-07-26 2019-07-26 Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique Active FR3099060B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1908575A FR3099060B1 (fr) 2019-07-26 2019-07-26 Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique
PCT/EP2020/070642 WO2021018682A1 (fr) 2019-07-26 2020-07-22 Complexe hybride mineral et organique et son utilisation pour le maintien de l'equilibre microbiologique de la peau et/ou d'une composition cosmetique et/ou dermopharmaceutique
CN202080053365.4A CN114667130A (zh) 2019-07-26 2020-07-22 杂化无机-有机复合物及其用于维持皮肤和/或化妆品和/或皮肤药物组合物的微生物平衡的用途
EP20740649.7A EP4003269A1 (fr) 2019-07-26 2020-07-22 Complexe hybride mineral et organique et son utilisation pour le maintien de l'equilibre microbiologique de la peau et/ou d'une composition cosmetique et/ou dermopharmaceutique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1908575A FR3099060B1 (fr) 2019-07-26 2019-07-26 Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique
FR1908575 2019-07-26

Publications (2)

Publication Number Publication Date
FR3099060A1 FR3099060A1 (fr) 2021-01-29
FR3099060B1 true FR3099060B1 (fr) 2022-01-14

Family

ID=68806993

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1908575A Active FR3099060B1 (fr) 2019-07-26 2019-07-26 Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique

Country Status (4)

Country Link
EP (1) EP4003269A1 (fr)
CN (1) CN114667130A (fr)
FR (1) FR3099060B1 (fr)
WO (1) WO2021018682A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927749A (en) * 1986-04-09 1990-05-22 Jeanette Simpson Reagent for cell separation
EP1379265A4 (fr) * 2001-03-28 2005-09-14 Helix Biomedix Inc Peptides bioactifs courts et leurs procedes d'utilisation
JP4409229B2 (ja) * 2003-08-06 2010-02-03 花王株式会社 共凝集抑制剤
WO2008018566A1 (fr) * 2006-08-10 2008-02-14 The Furukawa Electric Co., Ltd. Particule de silice colloïdale contenant une substance absorbant la lumière, un nanomatériau absorbant la lumière, un kit de nanoperle de marquage d'absorption, et un procédé de détection ou de quantification de molécules biologiques utilisant la particule de silice colloïdale contenant un
CN102391300A (zh) * 2011-08-30 2012-03-28 上海大学 含有谷胱甘肽gsh的有机/无机复合层状化合物及其制备方法
FR2992318B1 (fr) * 2012-06-22 2018-11-16 Centre Nat Rech Scient Materiaux hybrides peptide-silice
CN106552600B (zh) * 2016-10-18 2019-06-25 武汉理工大学 一种磁性壳核结构纳米粒子及其制备方法与应用

Also Published As

Publication number Publication date
FR3099060A1 (fr) 2021-01-29
CN114667130A (zh) 2022-06-24
EP4003269A1 (fr) 2022-06-01
WO2021018682A1 (fr) 2021-02-04

Similar Documents

Publication Publication Date Title
MX2022004874A (es) Compuestos de modulacion de glp-1r.
PH12020551261A1 (en) Il-15 conjugates and uses thereof
MA34555B1 (fr) Nouvelles protéines de liaison à un antigène
DK1951759T3 (da) Anti-EGFR-antistoffer
DE60319745D1 (de) Modifizierter löslicher t-zellen-rezeptor
MX2020007812A (es) Moduladores del receptor de quimiocina y usos de los mismos.
WO2004058171A3 (fr) Anticorps anti-gpr64 et utilisations
DE502006004084D1 (de) Kautschukmischung und reifen
EP1239049A3 (fr) Détermination de l'eau oxygenée avec des oxidases et des complexes lanthanoide-ligand
MA34025B1 (fr) Polypeptides se liant au bêta-a
MX342422B (es) Composiciones para aplicaciones de gel removible para uñas y metodos para su uso.
EA200702278A1 (ru) Антитела, специфичные в отношении tgf-бета 1
TW200621244A (en) Modulators of muscarinic receptors
PH12021551498A1 (en) Activatable masked anti-ctla4 binding proteins
WO2020051333A8 (fr) Anticorps anti-avb8, compositions et utilisations associées
WO2018052464A8 (fr) Procédés et systèmes pour essais multiplex
MX2022007288A (es) Agentes de union a ilt3 y metodos de uso de los mismos.
MX2022008684A (es) Anticuerpos que se unen a integrina avb8 y usos de los mismos.
MX2021005048A (es) Anticuerpos anti-ctla4, fragmentos de anticuerpos, sus inmunoconjugados y usos.
WO2021207948A9 (fr) Anticorps dirigés contre le sars-cov-2 et leurs utilisations
FR3099060B1 (fr) Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique
UA94705C2 (ru) Средства против эндопаразитов
ATE227760T1 (de) Mit nanopartikeln modifizierte bindemittel für überzugsmittel und deren verwendung
MX2009010288A (es) Dispositivo para la administracion de composiciones viscosas.
WO2019066396A3 (fr) Composition de caoutchouc

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210129

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5